A Japan-based manufacturer of in vitro diagnostic equipment and reagents used by hospitals and clinical laboratories worldwide. The company is best known for its hematology analyzers and related testing systems that help detect and monitor diseases through blood analysis. Investors track the firm as...
4 members of Congress have disclosed 19 trades in Sysmex Corporation (SSMXY), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 12 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-12-05 | Josh Gottheimer | sell | $1K – $15K |
| 2025-09-22 | Josh Gottheimer | buy | $1K – $15K |
| 2025-08-21 | Josh Gottheimer | sell | $1K – $15K |
| 2025-04-09 | Josh Gottheimer | sell | $1K – $15K |
| 2024-09-09 | Josh Gottheimer | buy | $1K – $15K |
| 2024-09-03 | Josh Gottheimer | buy | $1K – $15K |
| 2024-05-06 | Josh Gottheimer | buy | $1K – $15K |
| 2024-05-02 | Josh Gottheimer | buy | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | sell | $1K – $15K |
| 2021-02-17 | Peter Meijer | sell | $15K – $50K |
| 2021-01-28 | Peter Meijer | sell | $1K – $15K |
| 2020-08-04 | Greg Gianforte | buy | $15K – $50K |
| 2020-01-13 | Greg Gianforte | sell | $15K – $50K |
| 2018-12-21 | Greg Gianforte | buy | $15K – $50K |
| 2018-11-20 | Greg Gianforte | sell | $15K – $50K |
| 2018-09-18 | Josh Gottheimer | sell | $1K – $15K |
| 2018-09-12 | Greg Gianforte | sell | $50K – $100K |
| 2018-07-05 | Greg Gianforte | sell | $15K – $50K |